Search

everythinglearnresearchcommunity

for

Search:↓

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Bicalutamide may help treat female pattern hair loss.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

Few dermatology programs mention gender-affirming care, highlighting a need for better training and visibility.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

Understanding sex and gender differences can improve personalized dermatology care.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Facial hair is crucial for gender affirmation, but many face financial barriers to achieving desired results.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Many LGBTQ individuals in Lahore face skin issues, with androgenic alopecia, dry skin, and scabies being common, highlighting the need for better healthcare access and provider training.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Ciclosporin can cause excessive hair growth even with testosterone blockers.